Search Results 631-640 of 3870 for ❗[ 텔레 : ADSFIX01 ] 백링크홍보 구글찌라시프로그램판매 구글찌라시프로그램구매❗

  1. A Study of Cologuard™ in an Average Risk Population Assessing a Three Year Test Interval - Mayo Clinic

    The purpose of this study is to assess the impact of repeating Cologuard testing for colon cancer at 3 year intervals in average risk patients. Participation ...

  2. Role of the Neurogenic Niche in the Malignancy of Glioblastoma - Neurogenesis and Brain Tumors: Hugo Guerrero Cazares - Mayo Clinic Research

    Dr. Guerrero Cazares' Neurogenesis and Brain Tumors Lab at Mayo Clinic studies the neurogenic niche in the malignancy of glioblastoma.

  3. A Study of Pharmacogenomics Testing in Patients Who Experience Bleeding While on Apixaban or Warfarin - Mayo Clinic

    About this study. The purpose of htis study is to see if PGx testing will help to determine better ways for doctors to use apixaban treatment.

  4. Overview - Aspirin-Exacerbated Respiratory Disease: Elina Jerschow - Mayo Clinic Research

    The laboratory of Elina Jerschow, M.D., M.S., at Mayo Clinic studies aspirin-exacerbated respiratory disease (AERD) and related conditions.

  5. Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies - Mayo Clinic

    About this study. Primary Objective: Phase 1: To determine the maximum tolerated dose (MTD)/maximum administered dose (MAD) of SAR650984 (Isatuximab).

  6. A Study to Continue A Long Term Follow-Up of Patients Given Doxorubicin-Cyclophosphamide Therapy for Breast Cancer - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis - Mayo Clinic

    This first-in-human, double-blind, placebo-controlled Phase I study will be conducted in participants with amyotrophic lateral sclerosis (ALS) to explore safety ...

  8. Colorectal Cancer - eMERGE Genome Informed Risk Assessment - Mayo Clinic Research

    EPCAM. MLH1. MSH2. MSH6. STK11. PMS2. For participants with monogenic risk, the GIRA report recommends referral to a genetic counselor.

  9. A Study to Identify the Needs for and Develop a Communication Tool for Intensive Care Patients and Their Family - Mayo Clinic

    About this study. The purpose of the study is to identify the daily patient-specific information needs of intensive care unit patients and their families in ...

  10. Evaluation of a Stress Management Tool - Clinical Trials

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...